In this week's episode of #AskDrDurie, the IMF's Chairman Dr. Brian Durie answers a patient's question regarding how bone disease in myeloma is treated. He discusses bisphosphonates such as Aredia and Zometa and what the current recommendations are.
In this week's #AskDrDurie, the IMF's Dr. Brian Durie answers a very important question regarding the tests available for measuring Minimal Residual Disease. As you may know, the IMF's Black Swan Research Initiative(R) has been evaluating a new flow test method for this, and it is becoming a new benchmark.
In this week's #AskDrDurie episode, Dr. Brian Durie of the IMF explains the difference between x-rays, MRI, CT, and PET image scans. Each one has its place in detecting myeloma, and he walks viewers through each.
In this week's #AskDrDurie, IMF Chairman and Co-Founder, Dr. Brian Durie answers a patient's inquiry about the benefits and necessity of having an autologous stem cell transplant (ASCT) if treatment for myeloma has already been completed, with remission as the result.
In this episode of #AskDrDurie, IMF Co-Founder and Chairman Dr. Brian G.M. Durie answers a patient submitted question regarding receiving an initial diagnosis of standard myeloma, having treatment, and then being told the myeloma was high risk. He explains when and why that can happen and discusses different kinds of testing involved.
In this episode of #AskDrDurie, IMF Chairman and Co-Founder Dr. Brian G.M. Durie addresses a question about what kind of maintenance therapy is recommended for those myeloma patients who have the t(4;14) chromosome abnormality.
In this episode of #AskDrDurie, Dr. Brian Durie, IMF Chairman and Co-Founder, talks about the Black Swan Research Initiative(R)'s various clinical trials and how eligible patients can get more information and potentially participate in them.
In this episode of #AskDrDurie, Dr. Brian G.M. Durie, IMF Chairman, discusses the importance of early detection screenings in order to diagnose myeloma. Find out why there is a constant need for awareness and monitoring of any changes in test results.